AKT1 and hepatocellular carcinoma: Based on previous studies that identified NPTX1 as an epigenetic target, we speculate that in HCC, the AKT signaling pathway down-regulates NPTX1 by modulating the potential methyltransferases that catalyze the methylation of NPTX1.